跳至主要内容
临床试验/EUCTR2006-005331-25-GB
EUCTR2006-005331-25-GB进行中(未招募)1 期

A study to examine the influence of repaglinide on the 'incretin effect' and oxidative damage associated with postprandial

Swansea NHS Trust0 个研究点目标入组 30 人开始时间: 2007年1月1日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • •Type II Diabetics treated with Metformin
  • •Non smokers aged between 40 - 70 years males & females
  • •No acute concurrent illness
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •Patients with coronary heart disease
  • •Have proteinuria (albumin:creatnine ratio >30mg/mmol) and those with a serum creatinine >150mmol/l
  • •Patients taking vitamin supplementation

研究者

发起方
Swansea NHS Trust

相似试验